Form 8-K - Current report:
SEC Accession No. 0001628908-21-000132
Filing Date
2021-10-04
Accepted
2021-10-04 16:14:10
Documents
12
Period of Report
2021-10-01
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 2021.10.04 8-K evh-20211001.htm   iXBRL 8-K 38614
  Complete submission text file 0001628908-21-000132.txt   180523

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20211001.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20211001_lab.xml EX-101.LAB 25850
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20211001_pre.xml EX-101.PRE 13590
5 EXTRACTED XBRL INSTANCE DOCUMENT evh-20211001_htm.xml XML 11837
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 211302885
SIC: 8741 Services-Management Services